Purchase Order 75N93021P01457

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12,602.02 firm fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, on September 17, 2021, with an ultimate completion date of October 16, 2021. This contract was executed to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The work was performed at Life Technologies' facility in Grand Island, New York. No set-aside designation was utilized for this award, reflecting the contractor's specialized technological capabilities and proprietary product offerings.

Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools to federal agencies, specializing in scientific instruments, reagents, consumables, and laboratory equipment that support life sciences research and public health missions. The company maintains an extensive federal contracting presence with multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Veterans Affairs. Life Technologies currently holds active indefinite delivery vehicles, including a blanket purchase agreement with the Department of Veterans Affairs Veterans Integrated Service Network 15 for pathology and laboratory sequencing reagents, demonstrating the company's ongoing role in supporting federal genomic testing and precision medicine initiatives across the government.